(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release
Posted in Austria, European Union, France, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science, United Kingdom
Tagged biotechnology, CEBINA, Central European Biotech Incubator and Accelerator, clinical testing, Clinical Trail, Diarrhoeal diseases, Enterotoxigenic E. coli, ETEC, European Vaccine Initiative, Eveliqure, Eveliqure Biotechnologies, Eveliqure Biotechnologies GmbH, Frank Malinoski, Gábor Somogyi, Healthcare, Horizon 2020, icddr b, PATH, Pharma & Biotech, science, Shigella, ShigETEC, SHIGETECVAX, Travel Diarrhea, University of Gothenburg, vaccine candidate, Wellcome Trust
21-5-2013 — /europawire.eu/ — Men experience a higher burden of disease and lower life expectancy than women, but policies focusing on the health needs of men are notably absent from the strategies of global health organisations, according to a Viewpoint article in this … Read the full press release
Posted in Healthcare, Society, United Kingdom
Tagged Cerebrovascular disease, Chronic obstructive pulmonary disease, Diarrhoeal diseases, disability, disease, disease on men, Global health policy, health policy, HIV/AIDS, Ischemic heart disease, Low back pain, Lower respiratory infections, malaria, premature death, Preterm birth complications, Road injury, University College London
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
